Literature DB >> 18373985

Therapeutic role of sirtuins in neurodegenerative disease.

Tiago Fleming Outeiro1, Oldriska Marques, Aleksey Kazantsev.   

Abstract

The sirtuins are a family of enzymes which control diverse and vital cellular functions, including metabolism and aging. Manipulations of sirtuin activities cause activation of anti-apoptotic, anti-inflammatory, anti-stress responses, and the modulation of an aggregation of proteins involved in neurodegenerative disorders. Recently, sirtuins were found to be disease-modifiers in various models of neurodegeneration. However, almost in all instances, the exact mechanisms of neuroprotection remain elusive. Nevertheless, the manipulation of sirtuin activities is appealing as a novel therapeutic strategy for the treatment of currently fatal human disorders such as Alzheimer's and Parkinson's diseases. Here, we review current data which support the putative therapeutic roles of sirtuin in aging and in neurodegenerative diseases and the feasibility of the development of sirtuin-based therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18373985     DOI: 10.1016/j.bbadis.2008.02.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  37 in total

Review 1.  Sirtuins in neurodegenerative diseases: a biological-chemical perspective.

Authors:  Aparna Raghavan; Zahoor A Shah
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

2.  A mechanism-based potent sirtuin inhibitor containing Nε-thiocarbamoyl-lysine (TuAcK).

Authors:  Brett M Hirsch; Yujun Hao; Xiaopeng Li; Chrys Wesdemiotis; Zhenghe Wang; Weiping Zheng
Journal:  Bioorg Med Chem Lett       Date:  2011-06-22       Impact factor: 2.823

3.  Asiatic acid, a pentacyclic triterpene in Centella asiatica, attenuates glutamate-induced cognitive deficits in mice and apoptosis in SH-SY5Y cells.

Authors:  Min-fang Xu; Yu-yun Xiong; Jian-kang Liu; Jin-jun Qian; Li Zhu; Jing Gao
Journal:  Acta Pharmacol Sin       Date:  2012-03-26       Impact factor: 6.150

Review 4.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

Review 5.  Molecular Pathogenesis and Interventional Strategies for Alzheimer's Disease: Promises and Pitfalls.

Authors:  Shashikala Bhute; Deepaneeta Sarmah; Aishika Datta; Pallavi Rane; Amit Shard; Avirag Goswami; Anupom Borah; Kiran Kalia; Kunjan R Dave; Pallab Bhattacharya
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-26

Review 6.  Complex neuroprotective and neurotoxic effects of histone deacetylases.

Authors:  Elizabeth A Thomas; Santosh R D'Mello
Journal:  J Neurochem       Date:  2018-04-06       Impact factor: 5.372

Review 7.  Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders?

Authors:  Mohammad Jodeiri Farshbaf; Kamran Ghaedi; Timothy L Megraw; Jennifer Curtiss; Mahsa Shirani Faradonbeh; Pooneh Vaziri; Mohammad Hossein Nasr-Esfahani
Journal:  Neuromolecular Med       Date:  2015-11-26       Impact factor: 3.843

Review 8.  The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?

Authors:  Junghee Lee; Jung Hyun Boo; Hoon Ryu
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

9.  Neurodegeneration Alters Metabolic Profile and Sirt 1 Signaling in High-Fat-Induced Obese Mice.

Authors:  Leandro Ceotto Freitas Lima; Soraya Wilke Saliba; João Marcus Oliveira Andrade; Maria Luisa Cunha; Puebla Cassini-Vieira; John David Feltenberger; Lucíola Silva Barcelos; André Luiz Sena Guimarães; Alfredo Mauricio Batista de-Paula; Antônio Carlos Pinheiro de Oliveira; Sérgio Henrique Sousa Santos
Journal:  Mol Neurobiol       Date:  2016-05-16       Impact factor: 5.590

10.  Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease.

Authors:  Carl Julien; Cyntia Tremblay; Vincent Emond; Meryem Lebbadi; Norman Salem; David A Bennett; Frédéric Calon
Journal:  J Neuropathol Exp Neurol       Date:  2009-01       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.